Basic Information
| LncRNA/CircRNA Name | ARlnc1 |
| Synonyms | PRCAT47, LINC02170 |
| Region | GRCh38_16:80828735-80892595 |
| Ensemble | ENSG00000260896 |
| Refseq | NR_131947 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | RNA-seq, qPCR, Northern blot etc. |
| Sample | cell lines |
| Expression Pattern | differential expression |
| Function Description | Taken together, these data support a role for ARLNC1 in maintaining a positive feedback loop that potentiates AR signaling during prostate cancer progression and identify ARLNC1 as a novel therapeutic target. |
| Pubmed ID | 29808028 |
| Year | 2018 |
| Title | Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression |
External Links
| Links for ARlnc1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |